Primary care rebate schemes (PCRS) are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s).
The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies. Entering into a rebate does not constitute endorsement by the CCG of that product. We are unable to publish the full details of the PCRS because this information is commercially sensitive. Health professionals should always base their prescribing decisions primarily on assessments of their individual patients’ clinical circumstances.
There are a number of PCRS available. NHS South East London CCG is signed up to the following PCRS:
|Companies Involved||Medicines covered||Borough/ SEL CCG Wide|
|Chiesi||Clenil rebate||SEL CCG|
|Chiesi||Fostair NEXTHaler||SEL CCG|
|Chiesi||Fostair MDI||SEL CCG|
|Ethypharm||Espranor rebate||SEL CCG|
|Merck Serono Limited||Glucophage rebate||SEL CCG|
|Convatec||Convatec primary care dressings rebate||SEL CCG|
|Daiichi Sankyo||Edoxaban||SEL CCG|
|Fontus||Aproderm emollients and barrier creams||SEL CCG|
|Abbot||Flash Glucose Monitoring Freestyle Libre||SEL CCG|
|AstraZeneca||Zoladex||Bexley, Bromley, Lewisham|